JERUSALEM (AP)-- Israeli
generic drug maker Teva Pharmaceutical Industries on Thursday said first - quarter earnings surged over 80 percent and raised...
JERUSALEM — Israeli
generic drug maker Teva Pharmaceutical Industries on Thursday said first - quarter earnings surged over 80 percent and raised its outlook for the rest of the year, citing progress in an aggressive restructuring plan.
Not exact matches
After
generic drug maker Actavis bought Allergan last year, it took the name of the specialty pharmaceutical company; the reinvented Allergan then turned around and sold its legacy
generic business to
Teva Pharmaceutical Industries (TEVA) in J
Teva Pharmaceutical Industries (
TEVA) in J
TEVA) in July.
Israel - based
Teva, the world's largest
maker of
generic drugs, has been looking at divestures to help pare its $ 35 billion debt pile.
** Specialty chemicals
maker Lonza Group AG said it was ending a
generic drugs venture with Israel's
Teva Pharmaceutical Industries by mutual agreement after misjudging how much it would cost.